View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Anthony Dick ... (+2)
  • Anthony Dick
  • Michael Foundoukidis

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 02/02/2024

Sodexo boasts a defensive profile and significant potential for operational improvement, with progress increasingly visible since Sophie Bellon’s arrival as CEO. These factors are set to endure, narrowing the gap with Compass, and its transformation into a catering pure player following Pluxee’s spin-off in early 2024 should facilitate the group’s rerating. Outperform rating reiterated and a target price € 98 following Pluxee’s spin-off (combined  Sodexo + Pluxee target price of € 12...

Anthony Dick ... (+2)
  • Anthony Dick
  • Michael Foundoukidis

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 02/02/2024

Sodexo bénéficie d’un profil défensif et d’un fort potentiel d’amélioration opérationnelle, avec des progrès de plus en plus visibles depuis l’arrivée de Sophie Bellon comme CEO. Ceux-ci devraient se poursuivre, réduisant l’écart avec Compass, et sa transformation en un pure player, à la suite du spin-off de Pluxee début 2024, devrait faciliter son rerating boursier. Surperformance réitérée et OC à 98 € à la suite du spin-off de Pluxee (OC combinés Sodexo + Pluxee à 129 € vs OC de 118...

Oliver Metzger
  • Oliver Metzger

Siemens Healthineers : Conference call showed no relief on China

>Q1 solid performance, but impacted by China - The Q1 results of Siemens Healthineers were driven by a strong performance of Varian supported not only by a healthy underlying demand for radiation, but also by a comparatively low base in Q1 2023. Imaging had a solid performance impacted by China. Diagnostics showed some top-line stabilisation (2+2% y-o-y) excluding the antigen, which is also a move into the right direction in our view. No relief in China - ...

Oliver Metzger
  • Oliver Metzger

Siemens Healthineers : Q1 review – Slight beat driven by Varian

>Slight beat at group level - Q1 revenues of € 5,176m (+4.2% y-o-y) were 4%/1% ahead of ODDO BHF/consensus estimates. The comparable sales growth was 5.7% (vs 3.7%/5.2% expected) still impacted by headwind from the Covid antigen test. Excluding the test, comparable sales growth would have been at a solid 7.0%. The equipment book-to-bill was at a level of 1.14x, following 1.16x at the Q4 results. Adjusted EBIT of € 742m (+14.7% y-o-y, margin 14.3%) was 5%/0% vs expecta...

Oliver Metzger
  • Oliver Metzger

Siemens Healthineers : Reassuring mid-term prospects

>Imaging – strong prospects driven by photon counting CT and MRI - The overall positive expectations for Imaging were confirmed. Innovations continue to be the driver of growth. Highlights were a deep discussion about Naeotom, the world’s first photon counting CT. The unique technology offers a significant higher resolution combined with a radiation dosage, which is c. 30% lower than the latest dual-source CT offering. We see a technological lead vs competitors for a ...

Oliver Metzger
  • Oliver Metzger

Siemens Healthineers : Slower start into 2024

>Finish driven by Varian - Q4 2023/24 revenues of € 6,056m (+1.0% y-o-y) were driven by comparable sales growth of 7.5% still impacted by some headwind from the Covid antigen test. Excluding the test, comparable sales growth would have been at a strong 10.8%. The positive development was driven by Varian, which showed a very strong 29.8% comparable sales growth. Hence, we like the positive trend of the equipment book-to-bill, which climbed to a level of 1.16x vs 1.11x...

Oliver Metzger
  • Oliver Metzger

Siemens Healthineers : Q4 review -positive finish driven by Varian, ou...

>Strong finish with beat on sales and adj. EBIT - Q4 revenues of € 6,056m (+1.0% y-o-y) were 2%/3% ahead of ODDO BHF/consensus estimates. The comparable sales growth was 7.5% (vs 4.3%/4.7% expected) impacted by headwind from the Covid antigen test. Excluding the test, comparable sales growth would have been at a strong 10.8%. The equipment book-to-bill was at a level of 1.16x, following 1.11x at the Q3 results. Adjusted EBIT of € 1,013m (+0.2% y-o-y, margin 16.7%) was...

Oliver Metzger ... (+3)
  • Oliver Metzger
  • Stephan Wulf
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/07/2023

Since its integration into our European Large Caps Convictions list on 11 January 2023, KPN has made a significant contribution to the list’s performance, thanks to its defensive profile and high dividend yield (11.33% total return). We have decided to take profits as the company is holding its Capital Market Day today. The outlook remains very bright, but the smaller-than-expected share buyback programme announced this morning in the group's press release could disappoint. - ...

Oliver Metzger ... (+3)
  • Oliver Metzger
  • Stephan Wulf
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 07/11/2023

Since its integration into our European Large Caps Convictions list on 11 January 2023, KPN has made a significant contribution to the list’s performance, thanks to its defensive profile and high dividend yield (11.33% total return). We have decided to take profits as the company is holding its Capital Market Day today. The outlook remains very bright, but the smaller-than-expected share buyback programme announced this morning in the group's press release could disappoint. - ...

Oliver Metzger
  • Oliver Metzger

Siemens Healthineers : Q4 due 8 November – Adjusting estimates ahead o...

>Q4 due 8 November – Solid quarter expected - Siemens Healthineers’ Q4 revenues of € 5,932m (-1.1% y-o-y, 1% vs consensus) should be driven by comparable sales growth of 4.3%, but should be hold back by forex headwind of 540bp. Imaging should show 7.9% comparable sales growth impacted by slight headwind from China. We forecast Diagnostics to be down by 13% on a comparable base, but to show some sequential improvement compared to Q3 (-20% y-o-y). On the other hand, Var...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch